NCT + PD1 + Ketogenic Diet and/or Vitamin C for LARC
A phase 2 trial of High-dose intravenous vitamin C in Rectal cancer, run by Sixth Affiliated Hospital, Sun Yat-sen University, not yet recruiting.
Overview
NCT + PD1 + Ketogenic Diet and/or Vitamin C for LARC is a phase 2 interventional study registered as NCT07765667 by Sixth Affiliated Hospital, Sun Yat-sen University, with 100 participants planned, started 2026-09-01 and due to reach its primary completion in 2029-09-01. Interventions recorded: Short-Course Radiotherapy, PD-1 monoclonal antibody, mFOLFOX6 regimen, Ketogenic Diet, Surgical resection, Vitamin C. Conditions recorded: Rectal Adenocarcinoma, High-Risk Cancer, MSS.
Linked to the technology High-dose intravenous vitamin C because the registry's title names it ("high dose intravenous vitamin c") and Rectal cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialPreoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer
Shares High-dose intravenous vitamin C, Rectal cancer and the tag pipeline.
- TrialPilot Trial of Intravenous Vitamin C in Refractory Non-Hodgkin Lymphoma (NHL)
Shares High-dose intravenous vitamin C and the tag pipeline.
- TrialOrgan Preservation in Rectal Cancer by Dose Escalated MR Guided Adaptive Radiotherapy
Shares Rectal cancer and the tag pipeline.
- TrialTo Evaluate Dose and Safety of NanoEcho Particle-1 Using NanoEcho Imaging Device Examinations of Rectal Lymph Nodes in Healthy Volunteers and Rectal Cancer Patients.
Shares Rectal cancer and the tag pipeline.
- TrialAdaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Shares Rectal cancer and the tag pipeline.
- TrialStudy of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation
Shares Rectal cancer and the tag pipeline.
- TrialA Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors
Shares FOLFOX (5-FU, leucovorin, oxaliplatin) and the tag pipeline.
- TrialMR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer
Shares Rectal cancer and the tag pipeline.